Proposition - PharmXpert Academy

More documents

Recommendations

Info

The Korean Pharmaceutical Company List 383 3. R&D Figures Year Actual 1996 Synthesized T.D.B, anti-ulcerativeSynthesized Non ammonia T.D.B, anti-ulcerative 1997 1999 2000 2001 2002 Synthesized Acemetacin, anti-inflammatory thirdly in the worldSynthesized Aceclofenac, NSAIDs secondly in the worldApplied for international patent of new anti-hepatitis material (PCT/KR97/00222, 71countries)Synthesized Policresulen, the advanced anti-septic & hemostatic, secondly in the world Established R&D centerSynthesized Triflusal, anti-thrombotic, secondly in the worldApplied for international patent of NSAIDs material ( PCT/KR99/00269)Developed the separation and refining technology of chiral amino acid firstly in KoreaManufactured DDB pill, Anti-hepatitis, firstly KoreaSynthesized Ferric Sodium Gluconate Complex, Anti-anemia, firstly in Korea Synthesized Polysaccharide Iron Complex, Anti-anemia, secondly in the world Synthesized Chromocarb Diethylamine, capillary protectantSynthesized Diclofenac-β-Dimethylaminoethanol, NSAIDs for injectionSynthesized Tiropramide HCl, Anti-spasmodicSynthesized DL-Penicillamine, non-natural amino acid Synthesized Diclofenac-β-Dimethylaminoethanol, NSAIDs for injectionSynthesized Tiropramide HCl, Anti-spasmodicSynthesized DL-Penicillamine, non-natural amino acid Acquired the CEP (Certification of Suitability of Monographs of the European Pharmacopoeia) for Acamprosate Calcium fromEDQM(European Directorate for the Quality of Medicines)Synthesized Afloqualone, muscle relaxants, secondly in the worldSynthesized Alibendol, treatment of dyspepsiaSynthesized Levosulpiride, treatment of functional dyspepsiaSynthesized L-Penicillamine, non-natural amino acidSynthesized Bendazac Lysine, treatment of cataractSynthesized Bendazac MicronizedSynthesized D-Penicillamine, non-natural amino acidSynthesized Hydramethylnon, insecticideSynthesized Roxatidine Acetate HCl, anti-ulcerative, firstly in KoreaSynthesized Etodolac Micronized, Anti-rheumatic 2003 Synthesized Glimepiride, anti-diabetic, firstly in Korea 2004 2005 Synthesized Droxidopa, Anti-parkinsonianSynthesized Ebastine, Anti histamineSynthesized Suplatast tosilate, Anti allergicSynthesized Fenoprofen calcium, Anti-inflammatorySynthesized Tandospirone citrate, Anti-depressantsSynthesized Pranlukast hydrate, Anti-asthmatic Synthesized Ecabet sodium, Anti- ulcerantsI Synthesized Gadopentetic Acid Monomeglumine Salt , MRI-contrastSynthesized Rebamipide, Anti-ulcerants Synthesized Gabapentine, Anti-convulsants.Synthesized Topiramate, Anti-convulsants. Synthesized Losartan potassium, Anti-hypertensive. 2006 Synthesized Gadodiamide, MRI Contrast Synthesized Tolterodine tartrate, Treatment of urinary incontinence
384 2007 Korea Pharmaceutical Industry Directory 4. Patent Information No The Name of Technology Application No. (Application date) Publication No. (Publication date) Priority No. Applied Country For Global Development Stage Future Plan Expected Licencing (Domestic, Oversea) 1 Processes for preparing 8-amino-4-oxo-2-(tetrazo 2006-0019942 l-5-yl)-4H-1-benzopyran (2006.03.02) or its salt and synthetic intermediates thereof 0739439 (2007.07.09) 2006-0019942 (2006.03.02) JP 2 A process for preparing pranlukast or its hydrate 2005-0050134 and a synthetic (2005.06.11) intermediate thereof 0686695 (2007.02.16) 2005-0050134 (2005.06.11) JP 3 Processes for preparing 2004-0014957 an optically active serine (2004.03.05) derivative 0458983 (2004.11.19) 2004-0014957 (2004.03.05) JP, PCT
Page 2 and 3:
2007 Korea Pharmaceutical Industry
Page 4 and 5:
2007 Korea Pharmaceutical Industry
Page 6 and 7:
27. ILYANG PHARM ·········
Page 8 and 9:
Chapter 1. Outline of The Project 2
Page 10 and 11:
Chapter 1. Outline of The Project 2
Page 12 and 13:
Chapter 2. Pharmaceutical Industry
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
The Annex
Page 38 and 39:
316 2007 Korea Pharmaceutical Indus
Page 40 and 41:
The Korean Pharmaceutical Company L
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55: The Korean Pharmaceutical Company L
Page 72 and 73: 4. Company Map The Korean Pharmace
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
4. Company Map The Korean Pharmace
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
show all

Proposition - PharmXpert Academy

Create successful ePaper yourself

Delete template?

Save as template?